Katz AM. Evolving concepts of heart failure: Cooling furnace, malfunctioning pump, enlarging muscle. Part I. Heart failure as a disorder of the cardiac pump. J Cardiac Failure 1997:3:319–334.
Katz AM. Evolving concepts of heart failure: Cooling furnace, malfunctioning pump, enlarging muscle. Part II. Hypertrophy and dilatation of the failing heart. J Cardiac Failure 1998:4:67–81.
Patterson SW, Piper H, Starling EH. The regulation of the ventricles. J Physiol (Lond) 1914:48:465–513.
Sutherland GA. The Lumleian Lectures on modern aspects of heart disease. Lancet1917:i:401–406, 437–442, 477–482.
Wiggers CJ. Physiology in Health and Disease. Philadelphia: Lea and Febiger, 1934.
Saxl P, Heilig R. Ñber die diureticheWirkung von Novasurol und anderen Quecksilberinjektionen.Wien klinWochenschr 1920:33:943–944.
Burch GE, Ray CT, Cronvick JA. Certain mechanical peculiarities of the human cardiac pump in normal and diseased states. Circulation 1952:5:504–513.
Burton AC. Importance of the shape and size of the heart. Am Heart J 1957:54:800–801.
Katz LN, Katz AM, Williams FL. Metabolic adjustments to alterations of cardiac work in hypoxemia. Am J Physiol 1955:181:539–549.
Evans CL, Matsuoka Y. The effect of various mechanical conditions on the gaseous metabolism and efficiency of the mammalian heart. J Physiol (Lond) 1915:49:378–405.
Sandler H, Dodge HT. Left ventricular tension and stress in man. Circ Res 1963:13:91–104.
Hood WP Jr, Rackley CE, Rolett EL.Wall stress in the normal and hypertrophied human left ventricle. Am J Cardiol 1968:22:5550–5558.
Grossman W, Jones D, McLaurin LP. Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest 1975:56:56–64.
Katz AM. Cardiomyopathy of overload. A major determinant of prognosis in congestive heart failure. New Eng J Med 1990:322:100–110.
Meerson FZ. On the mechanism of compensatory hyperfunction and insufficiency of the heart. Cor et Vasa 1961:3:161–177.
Alpert NR, Gordon MS. Myofibrillar adenosine triphosphatase activity in congestive heart failure. Am J Physiol 1962:202:940–946.
Lompré AM, Schwartz K, D'Albis A, Lacombe G, Thiem NV, Swynghdauw B. Myosin isozymes redistribution in chronic heart overloading. Nature 1979:282:105–107.
Izumo S, Lompré A-M, Matsuoka R, et al. Myosin heavy chain messenger RNA and protein isoform transitions during cardiac hypertrophy. J Clin Invest 1987:79:970–977.
Katz AM. Heart Failure: Pathophysiology, Molecular Biology, and Clinical Management. Philadelphia: Lippincott/ Williams & Wilkins, 2000.
Nagai R, Zarain-Herzberg A, Brandl CJ, et al. Regulation of myocardial Ca2+ ATPase and phospholamban mRNA expression in response to pressure overload and thyroid hormone. Proc Natl Acad Sci USA 1989:86:2966–2970.
De la Bastie D, Levitsky D, Rappaport L, et al. Function of the sarcoplasmic reticulum and expression of its Ca2+ ATPase gene in pressure-overloaded cardiac hypertrophy in the rat. Circ Res 1990:66:554–564.
Komuro I, Kurabayashi M, Shibazaki Y, Takaku F, Yazaki Y. Molecular cloning and characterization of a Ca2++ Mg2+-dependent adenosine triphosphatase from rat cardiac sarcoplasmic reticulum. Regulation of its expression by pressure overload and developmental stage. J Clin Invest 1989:83:1102–1108.
Katz AM. Physiology of the Heart, 3rd edn. Philadelphia: Lippincott/Williams & Wilkins, 2001.
Pogwizd SM, Schlotthauer K, Li L, Yuan W, Bers DM. Arrhythmogenesis and contractile dysfunction in heart failure: Roles of sodium-calcium exchange, inward rectifier potassium current, and residual beta-adrenergic responsiveness. Circ Res 2001:88:1159–1167.
Linzbach AJ. Heart failure from the point of view of quantitative anatomy. Am J Cardiol 1960:5:370–382.
Beltrami CA, Finato N, Rocco M, et al. Structural basis for end-stage failure in ischemic cardiomyopathy in humans. Circulation 1994:89:151–163.
Olivetti G, Capasso JM, Sonnenblick EH, Anversa P. Sideto-side slippage of myocytes participates in ventricular wall remodeling acutely after myocardial infarction in rats. Circ Res 1990:67:23–34.
Kajstura J, Zhang X, Reiss K, et al. Myocyte cellular hyperplasia and myocyte cellular hypertrophy contribute to chronic ventricular remodeling in coronary artery narrowing-induced cardiomyopathy in rats. Circ Res 1994:74:383–400.
Beltrami AP, Urbanek K, Kajstura J, et al. Evidence that human cardiac myocytes divide after myocardial infarction. New Eng J Med 2001:344:11750–11757.
Quaini F, Urbanek K, Beltrami AP, et al. Chimerism of the transplanted heart. New Eng J Med 2002:346:5–15.
Rumyantsev PP. Interrelations of the proliferation and differentiation processes during cardiac myogenesis and regeneration. Int Rev Cytol 1977:51:187–273.
Gerdes AM, Kellerman SE, Moore JA, et al. Structural remodeling of cardiac myocytes in patients with ischemic cardiomyopathy. Circulation 1992:85:426–430.
Gerdes AM, Kellerman SE, Malec KB, Schocken DD. Transverse shape characteristics of cardiac myocytes from rats and humans. Cardioscience 1994:5:31–36.
Gerdes AM, Capasso JM. Editorial review: Structural remodeling and mechanical dysfunction of cardiac myocytes in heart failure. J Mol Cell Cardiol 1995:27:849–856.
Fothergill JM. The Heart and its Diseases. 2nd edn. Philadelphia: Lindsay and Blakiston, 1879.
Yamamoto K, Dang QN, Maeda Y, Huang H, Kelly RA, Lee RT. Regulation of cardiac myocyte mechanotransduction by the cardiac cycle. Circulation 2001:103:1459–1464.
Aberle H, Schwartz H, Kemler R. Cadherin-catenin complex: Protein interactions and their implications for cadherin function. J Cell Biochem 1996:61:514–523.
Meredith JE Jr, Winitz S, Lewis JM, et al. The regulation of growth and intracellular signaling by integrins. Endoc Rev 1996:17:207–220.
Assoian RK, Zhu X. Cell anchorage and the cytoskeleton as partners in growth factor dependent cell cycle progression. Curr Opin Cell Biol 1997:9:93–98.
Giancotti FG. Integrin signaling: Specificity and control of cell survival and cell cycle progression. Curr Opinion Cell Biol 1997:9:691–700.
Hsueh WA, Law RE, Do YS. Integrins, adhesion, and cardiac remodeling. Hypertension 1997:31:176–180.
Lafrenie RM, Yamada KM. Integrin-dependent signal transduction. J Cell Develop Biol 1997:61:543–553.
Yap AS, Brieher WM, Gumbiner BM. Molecular and functional analysis of cadherin-based adherens junction. Ann Rev Cell Develop Biol 1997:13:119–146.
Wollert KC, Taga T, Saito M, et al. Corticotrophin-1 activates a distinct form of cardiac muscle cell hypertrophy. Assembly of sarcomeric units in series via gp130/leukemia inhibitory factor receptor-dependent pathways. J Biol Chem 1996:271:9535–9545.
Pfeffer JM, Pfeffer MA, Braunwald E. Influence of chronic captopril therapy on the infarcted left ventricle of the rat. Circ Res 1985:57:84–95.
Pfeffer MA, Pfeffer JM, Steinberg C, Finn P. Survival after experimental myocardial infarction: Beneficial effects of long-term therapy with captopril. Circulation 1985:72:406–412.
Pfeffer MA, Lamas GA, Vaughan DE, Parisi AF, Braunwald E. Effect of captopril on progressive left ventricular dilatation after anterior myocardial infarction.NEngl JMed 1988:319:80–86.
Sharpe N, Murphy J, Smith H, Hannan S. Treatment of patients with symptomless left ventricular dysfunction after myocardial infarction. Lancet 1988:1:255–259.
Smith H, Hannan S. Preventive treatment of asymptomatic left ventricular dysfunction following myocardial infarction. Eur Heart J 1990:11:S147–S156.
Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction: Experimental observations and clinical implications. Circulation 1990:81:1161–1172.
Sharpe N, Smith H, Murphy J, Greaves S, Hart H, Gamble G. Early prevention of left ventricular dysfunction after myocardial infarction with angiotensin converting-enzyme inhibition. Lancet 1991:337:872–876.
Oldroyd KG, PyeMP, Ray SG, et al. Effects of early captopril administration on infarct expansion, left ventricular remodeling and exercise capacity after acute myocardial infarction. Am J Cardiol 1991:68:713–718.
Mitchell GF, Lamas GA, Vaughan DE, Pfeffer MA. Left ventricular remodeling in the year after first anterior myocardial infarction: A quantitative analysis of contractile segment lengths and ventricular shape. J Am Coll Cardiol 1992:19:1136–1144.
Hayashida W, van Eyll C, Rousseau HF, Pouleur H for the SOLVDInvestigators. Regional remodeling and nonuniform changes in diastolic function in patients with left ventricular dysfunction: Modification by long-term enalapril treatment. J Am Coll Cardiol 1993:22:1403–1410.
McDonald KM, Rector T, Carlyle PF, Francis GS, Cohn JN. Angiotensin-converting enzyme inhibition and betaadrenoreceptor blockade regress established ventricular remodeling in a canine model of discrete myocardial damage. J Am Coll Cardiol 1994:24:1762–1768.
St John Sutton M, Pfeffer MA, Moye L, et al. for the SAVE Investigators. Cardiovascular death and left ventricular remodeling two years after myocardial infarction: Baseline predictors and impact of long-term use of captopril: Information from the survival and ventricular enlargement (SAVE) trial. Circulation 1997:96:3294–3299.
Greenberg B, Quinones MA, Koilpillai C, et al. for the SOLVD Investigators. Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction. Results of the SOLVD echocardiography substudy. Circulation 1995:91:2573–2581.
Hall SA, Cigarroa CG, Marcoux L, Risser RC, Grayburn PA, Eichhorn EJ. Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade. J Am Coll Cardiol 1995:25:1154–1161.
Doughty RN, Whalley GA, Gamble G, MacMahon S, Sharpe N on behalf of the Australia-New Zealand Heart Failure Research Collaborative Group. Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease. J Am Coll Cardiol 1997:29:1060–1066.
Basu S, Senior R, Raval U, van der Does R, Bruckner T, Lahiri A. Beneficial effects of intravenous and oral carvedilol treatment in acute myocardial infarction. A placebo-controlled randomized trial. Circulation 1997:96: 183–191.
Lowes BD, Gill EA, Abraham WT, et al. Effects of carvedilol on left ventricular mass, chamber geometry, and mitral regurgitation in chronic heart failure. Am J Cardiol 1999:83:1201–1205.
Senior R, Basu S, Kinsey C, Schaeffer S, Lahiri A. Carvedilol prevents remodeling in patients with left ventricular dysfunction following acute myocardial infarction. Am Heart J 1999:137:646–652.
Ricci R, Coletta C, Ceci V, et al. on behalf of the RIMA Researchers. Effect of early treatment with captopril and metoprolol singly and together on postinfarction left ventricular remodeling. Am Heart J 2001:142:e5.
Khattar RS, Senior R, Soman P, van der Does R, Lahiri A. Regression of left ventricular remodeling in chronic heart failure: Comparative and combined effects of captopril and carvedilol. Am Heart J 2001:142:704–713.
Eichhorn EJ, Bristow MR. Medical therapy can improve the biological properties of the chronically failing heart. Circulation 1996:94:2285–2296.
Mann DL. Mechanisms and models in heart failure: A combinatorial approach. Circulation 1999:100:999–1008.
Chien KR. Stress pathways and heart failure. Cell 1999:98:555–558.
Kang PM, Izumo S. Apoptosis and heart failure: A critical review of the literature. Circ Res 2000:86:1107–1113.